Transcriptome Analysis of Human Dermal Cells Infected with Candida auris Identified Unique Pathogenesis/Defensive Mechanisms Particularly Ferroptosis.

Autor: Fayed B; Research Institute for Medical and Health Sciences, University of Sharjah, P.O. Box 27272, Sharjah, UAE.; Chemistry of Natural and Microbial Products, National Research Centre, Cairo, Egypt., Shakartalla SB; Research Institute for Medical and Health Sciences, University of Sharjah, P.O. Box 27272, Sharjah, UAE.; College of Medicine, University of Sharjah, P.O. Box 27272, Sharjah, UAE.; Faculty of Pharmacy, University of Gezira, P.O.Box. 21111, Wad Medani, Sudan., Sabbah H; AbbVie BioPharmaceuticals, P.O. Box 118052, Dubai, UAE., Dalle H; AbbVie BioPharmaceuticals, Kuwait City, Kuwait., Tannira M; AbbVie BioPharmaceuticals, P.O. Box 118052, Dubai, UAE., Senok A; College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Building 14 Dubai Healthcare City, P.O.Box 505055, Dubai, UAE., Soliman SSM; Research Institute for Medical and Health Sciences, University of Sharjah, P.O. Box 27272, Sharjah, UAE. ssoliman@sharjah.ac.ae.; Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, P.O. Box 27272, Sharjah, UAE. ssoliman@sharjah.ac.ae.

Publikováno v: Mycopathologia [Mycopathologia] 2024 Jul 11; Vol. 189 (4), pp. 65. Date of Electronic Publication: 2024 Jul 11.

Humanistic and Economic Burden of Atopic Dermatitis for Adults and Adolescents in the Middle East and Africa Region.

Autor: Elezbawy B; Syreon Middle East, 142 Elshaheed Galal Eldesouky Street, Alexandria, Egypt. baher.elezbawy@syreon.eu., Fasseeh AN; Syreon Middle East, 142 Elshaheed Galal Eldesouky Street, Alexandria, Egypt., Fouly E; Syreon Middle East, Dubai, United Arab Emirates., Tannira M; AbbVie BioPharmaceuticals, Dubai, United Arab Emirates., Dalle H; AbbVie BioPharmaceuticals, Kuwait City, Kuwait., Aderian S; AbbVie BioPharmaceuticals, Beirut, Lebanon., Abu Esba LC; Pharmaceutical Care Department, Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Riyadh, Saudi Arabia.; King Abdullah International Medical Research Center, Riyadh, Saudi Arabia.; College of Pharmacy, King Saud Bin Abdul Aziz University for Health Sciences, Riyadh, Saudi Arabia., Al Abdulkarim H; Drug Policy and Economic Center, Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Riyadh, Saudi Arabia., Ammoury A; St George's University Medical Center, Beirut, Lebanon., Altawil E; Clinical Pharmacy Department, King Saud University Medical City, Riyadh, Saudi Arabia., Al Turaiki A; Pharmaceutical Care Department, Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Riyadh, Saudi Arabia., Albreiki F; Department of Dermatology, Tawam Hospital, Al Ain, United Arab Emirates., Al-Haddab M; Department of Dermatology, College of Medicine, King Saud University, Riyadh, Saudi Arabia., Al-Lafi A; Department of Dermatology, As'ad Al Hamad Dermatology Centre, Shuwaikh Medical, Kuwait City, Kuwait., Alowayesh M; Department of Pharmacy Practice, Faculty of Pharmacy, Kuwait University, Kuwait City, Kuwait., Al-Sheikh A; Dermatology Department, Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Riyadh, Saudi Arabia., Elsayed M; Ain Shams University, Cairo, Egypt., Elshamy A; Wellbeing Office, Public Health Sector, Ministry of Health and Prevention, Dubai, United Arab Emirates., Eshmawi M; King Abdullah Medical Complex, Jeddah, Saudi Arabia., Farag A; Ain Shams University, Cairo, Egypt., Hamadah I; King Faisal Specialist Hospital & Research Center, Riyadh, Saudi Arabia., Hedibel M; Faculty of Pharmacy, University of Algiers, Algiers, Algeria., Kannenberg S; Stellenbosch University, Cape Town, South Africa., Karam R; Faculty of Sciences and Medical Sciences, Lebanese University, Beirut, Lebanon., Metni M; Faculty of Sciences, Lebanese University, Beirut, Lebanon., Raboobee N; Westville Hospital, Durban, South Africa., Steinhoff M; Hamad Medical Corporation, Doha, Qatar.; Department of Dermatology, Weill Cornell Medicine, New York, USA., Abaza S; Syreon Middle East, Cairo, Egypt., Farghaly M; Insurance Medical Regulation, Dubai Health Authority, Dubai, United Arab Emirates., Kaló Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.; Syreon Research Institute, Budapest, Hungary.

Publikováno v: Dermatology and therapy [Dermatol Ther (Heidelb)] 2023 Jan; Vol. 13 (1), pp. 131-146. Date of Electronic Publication: 2022 Nov 29.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

POSB168 The Burden of Atopic Dermatitis in Adults and Adolescents: A Systematic Literature Review

Autor: Fasseeh, AN, Elezbawy, B, Tannira, M, Dalle, H, Aderian, S, Abaza, S, Kalo, Z

Publikováno v: In Value in Health January 2022 25(1) Supplement:S127-S127

The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia.

Autor: Elezbawy B; Syreon Middle East, Alexandria, Egypt., Fasseeh AN; Syreon Middle East, Alexandria, Egypt., Fouly E; Syreon Middle East, Dubai, UAE., Esba LCA; Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Saudi Arabia., Al Abdulkarim H; Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Saudi Arabia., Al-Haddab M; King Saud University Medical City, Riyadh, Saudi Arabia., Al-Sheikh A; Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Saudi Arabia., Altawil E; King Saud University Medical City, Riyadh, Saudi Arabia., Al Turaiki A; Ministry of National Guard-Health Affairs, King Abdul Aziz Medical City, Saudi Arabia., Eshmawi M; King Abdullah Medical Complex, Jeddah, Saudi Arabia., Hamadah I; King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia., Tannira M; AbbVie BioPharmaceuticals, Dubai, UAE., Dalle H; AbbVie BioPharmaceuticals, Kuwait City, Kuwait., Aderian S; AbbVie BioPharmaceuticals, Beirut, Lebanon., Roshdy A; AbbVie BioPharmaceuticals, Riyadh, Saudi Arabia., Jaheen A; AbbVie BioPharmaceuticals, Riyadh, Saudi Arabia., Hamad T; AbbVie BioPharmaceuticals, Riyadh, Saudi Arabia., Abaza S; Syreon Middle East, Cairo, Egypt., Kaló Z; Center for Health Technology Assessment, Semmelweis University, Budapest, Hungary.; Syreon Research Institute, Budapest, Hungary.

Publikováno v: Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 1231-1239.